{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:28Z","timestamp":1786119448034,"version":"build-2736575974"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/spc.0b013e328339429a","type":"journal-article","created":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T01:55:37Z","timestamp":1272678937000},"page":"97-106","source":"Crossref","is-referenced-by-count":16,"title":["The management of painful crisis in sickle cell disease"],"prefix":"10.1097","volume":"4","author":[{"given":"Josh","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam H","family":"Ahmedzai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20211004","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anaemia, a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"key":"R2-9-20211004","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/178792a0","article-title":"A specific chemical difference between globulins of normal haemoglobin and sickle cell anaemia haemoglobin.","volume":"178","year":"1956","journal-title":"Nature"},{"key":"R3-9-20211004","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2141.1996.284816.x","article-title":"Determinants of haemoglobin level in steady state homozygous sickle cell disease","volume":"92","author":"Serjeant","year":"1996","journal-title":"Br J Haem"},{"key":"R4-9-20211004","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell free haemoglobin limits nitric oxide availability in sickle cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nature Med"},{"key":"R6-9-20211004","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"key":"R7-9-20211004","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0009-9260(89)80255-7","article-title":"Imaging the bone marrow with magnetic resonance during a crisis and in chronic forms of sickle cell disease","volume":"40","author":"Van Zanten","year":"1989","journal-title":"Clin Radiol"},{"key":"R8-9-20211004","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0140-6736(93)90418-G","article-title":"Is there an acute phase response in steady state sickle disease?","volume":"341","author":"Singhal","year":"1993","journal-title":"Lancet"},{"key":"R9-9-20211004","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/jcp.47.2.166","article-title":"Monitoring the acute phase response to vaso-occlusive crisis in sickle cell disease","volume":"47","author":"Stuart","year":"1994","journal-title":"J Clin Path"},{"key":"R11-9-20211004","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1526-4637.2009.00601.x","article-title":"Pain syndromes in sickle cell disease: an update","volume":"10","author":"Niscola","year":"2009","journal-title":"Pain Med"},{"key":"R12-9-20211004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.pain.2009.06.029","article-title":"Pain site frequency and location in sickle cell disease: the PiSCES project","volume":"145","author":"McClish","year":"2009","journal-title":"Pain"},{"key":"R13-9-20211004","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1089\/jwh.2006.15.146","article-title":"Gender differences in pain and healthcare utilisation for adult sickle cell patients: the PiSCES project","volume":"15","author":"McClish","year":"2006","journal-title":"J Women's Health"},{"key":"R14-9-20211004","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2141.1994.tb08317.x","article-title":"The painful crisis of homozygous sickle cell disease: clinical features","volume":"87","author":"Serjeant","year":"1994","journal-title":"Br J Haem"},{"key":"R15-9-20211004","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bmj.1.6001.66","article-title":"Climate and painful crisis of sickle cell disease in Jamaica","volume":"1","author":"Redwood","year":"1976","journal-title":"Br Med J"},{"key":"R16-9-20211004","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2141.2005.05799.x","article-title":"Windy weather and low humidity are associated with an increased number of hospital admissions for acute pain and sickle cell disease in an urban environment with a maritime temperate climate","volume":"131","author":"Jones","year":"2005","journal-title":"Br J Haem"},{"key":"R17-9-20211004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/adc.84.2.156","article-title":"Significance of fever in Jamaican patients with homozygous sickle cell disease","volume":"84","author":"Weirenga","year":"2001","journal-title":"Arch Dis Child"},{"key":"R18-9-20211004","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-3476(97)70201-4","article-title":"Septicaemia caused by salmonella infection; an overlooked complication of sickle cell disease","volume":"130","author":"Wright","year":"1997","journal-title":"J Pediatr"},{"key":"R19-9-20211004","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbrc.2009.09.102","article-title":"Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis","volume":"390","author":"van Tits","year":"2009","journal-title":"Biochem Biophys Res Communic"},{"key":"R20-9-20211004","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1259\/0007-1285-46-551-943","article-title":"Homozygous sickle cell disease in Jamaica","volume":"46","author":"Ennis","year":"1973","journal-title":"Br J Radiol"},{"key":"R21-9-20211004","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/bmj.326.7390.635","article-title":"Recent developments: management of pain","volume":"326","author":"Holdcroft","year":"2003","journal-title":"Br Med J"},{"key":"R22-9-20211004","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tins.2009.07.007","article-title":"Critical role of nociceptor plasticity in chronic pain","volume":"32","author":"Reichling","year":"2009","journal-title":"Trends Neurosci"},{"key":"R23-9-20211004","doi-asserted-by":"crossref","first-page":"8360","DOI":"10.1073\/pnas.122231899","article-title":"Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain","volume":"99","author":"Xiao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R24-9-20211004","first-page":"1","article-title":"Opioid-induced hyperalgesia","volume":"16","author":"Mao","year":"2008","journal-title":"Pain Clin Updates"},{"key":"R25-9-20211004","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00000542-200603000-00023","article-title":"Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase","volume":"104","author":"C\u00e9l\u00e9rier","year":"2006","journal-title":"Anesthesiology"},{"key":"R26-9-20211004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3959(03)00276-8","article-title":"Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal","volume":"106","author":"Angst","year":"2003","journal-title":"Pain"},{"key":"R27-9-20211004","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3324\/haematol.10937","article-title":"Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort study","volume":"92","author":"Telfer","year":"2007","journal-title":"Haematologica"},{"key":"R28-9-20211004","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1056\/NEJMp058274","article-title":"Prevention of stroke in sickle cell anaemia","volume":"353","author":"Platt","year":"2005","journal-title":"N Engl J Med"},{"key":"R29-9-20211004","first-page":"2769","article-title":"Optimizing primary stroke prevention in sickle cell anaemia (STOP2) trial investigators","volume":"353","author":"Adams","year":"2005","journal-title":"N Engl J Med"},{"key":"R30-9-20211004","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood-2007-07-089144","article-title":"Treatment and prevention of pain in adults with sickle cell disease. An educational void","volume":"111","author":"Solomon","year":"2008","journal-title":"Blood"},{"key":"R31-9-20211004","first-page":"94","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ass of Int Med"},{"key":"R32-9-20211004","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PSY.0b013e31815ff5c5","article-title":"Depression and anxiety in adults with sickle cell disease; the PISCES project","volume":"70","author":"Levenson","year":"2008","journal-title":"Psychosom Med"},{"key":"R33-9-20211004","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.pain.2007.02.008","article-title":"The role of catastrophising in sickle cell disease: the PiSCES project","volume":"133","author":"Citero","year":"2007","journal-title":"Pain"},{"key":"R34-9-20211004","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1477-7525-3-50","article-title":"Health related quality of life in sickle cell patients: the PiSCES project","volume":"3","author":"McCLish","year":"2005","journal-title":"Health Qual Life Outcomes"},{"key":"R35-9-20211004","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-7-75","article-title":"Utility of WHOQOL-BREF in measuring quality of life in sickle cell disease","volume":"7","author":"Asnani","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"R36-9-20211004","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1586\/erp.09.32","article-title":"Pain management and quality of life in sickle cell disease","volume":"9","author":"Howard","year":"2009","journal-title":"Exp Rev Pharmacoecon Outcomes Res"},{"key":"R37-9-20211004","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/pbc.22222","article-title":"Vaso-occlusive painful events in sickle cell disease: impact on child well being","volume":"54","author":"Brandow","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R38-9-20211004","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.annemergmed.2008.07.050","article-title":"Comparisons of high versus low emergency department utilizers in sickle cell disease","volume":"53","author":"Aisuku","year":"2009","journal-title":"Ann Emerg Med"},{"key":"R39-9-20211004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.12968\/bjon.2009.18.3.39043","article-title":"Barriers to effective pain management in sickle cell disease","volume":"18","author":"Wright","year":"2009","journal-title":"Br J Nurs"},{"key":"R40-9-20211004","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","article-title":"Effect of HU on the frequency of painful crisis in SCA","volume":"332","author":"Charach","year":"1995","journal-title":"N Engl J Med"},{"key":"R41-9-20211004","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of HU on mortality and morbidity in adult SCA: notes and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"J Am Med Assoc"},{"key":"R42-9-20211004","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1542\/peds.2008-0441","article-title":"Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children","volume":"122","author":"Strouse","year":"2008","journal-title":"Pediatrics"},{"key":"R43-9-20211004","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea in adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Int Med"},{"key":"R44-9-20211004","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"Br J Haem"},{"key":"R45-9-20211004","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s00520-006-0086-x","article-title":"The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it?","volume":"14","author":"Ferreira","year":"2006","journal-title":"Support Care Cancer"},{"key":"R47-9-20211004","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/pbc.20403","article-title":"Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome","volume":"45","author":"Buchanan","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"R48-9-20211004","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/ajh.20944","article-title":"Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial","volume":"82","author":"van Beers","year":"2007","journal-title":"Am J Hematol"},{"key":"R49-9-20211004","first-page":"984","article-title":"Outpatient management of sickle cell pain with chronic opioid pharmacotherapy","volume":"96","author":"Shaiova","year":"2004","journal-title":"J Natl Med Assoc"},{"key":"R50-9-20211004","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/j.1526-4637.2006.00269.x","article-title":"Recognition and diagnosis of breakthrough pain","volume":"8","author":"Payne","year":"2007","journal-title":"Pain Med"},{"key":"R51-9-20211004","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/pbc.22395","article-title":"Inpatient use of laxatives during opioid administration in children with sickle cell disease","volume":"54","author":"O'Brien","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R53-9-20211004","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1016\/j.clinthera.2007.12.016","article-title":"Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study","volume":"29","author":"Finkelstein","year":"2007","journal-title":"Clin Ther"},{"key":"R54-9-20211004","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s11916-009-0047-4","article-title":"The management of sickle cell disease","volume":"13","author":"Richard","year":"2009","journal-title":"Curr Pain Headache Rep"},{"key":"R55-9-20211004","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood-2009-06-227330","article-title":"A randomised controlled clinical trial of ketoprofen for sickle cell disease vaso-occlusive crises in adults","volume":"114","author":"Bartolucci","year":"2009","journal-title":"Blood"},{"key":"R59-9-20211004","first-page":"1","article-title":"Palliative medicine and modern cancer care","volume":"27","author":"Ahmedzai","year":"2000","journal-title":"Semin Oncol"},{"key":"R60-9-20211004","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1182\/blood.V95.4.1130.003k03a_1130_1136","article-title":"Sickle cell anaemia day hospital: an approach for the management of uncomplicated crisis","volume":"95","author":"Benjamin","year":"2000","journal-title":"Blood"},{"key":"R61-9-20211004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1046\/j.1365-2141.1999.01160.x","article-title":"Day care management of sickle cell painful crisis in Jamaica: a model applicable elsewhere","volume":"104","author":"Ware","year":"1999","journal-title":"Br J Haem"},{"key":"R62-9-20211004","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/j.1365-2141.2004.05123.x","article-title":"Day case management of sickle pain: 3 years experience in a UK sickle cell unit","volume":"126","author":"Wright","year":"2004","journal-title":"Br J Haem"},{"key":"R63-9-20211004","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/SPC.0b013e3282f04e0c","article-title":"Opioids for chronic pain: molecular and genomic basis of actions and adverse effects","volume":"1","author":"Ahmedzai","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"R64-9-20211004","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/00000542-200209000-00007","article-title":"A randomized study of the effects of single-dose gabapentin versus placebo on postoperative pain and morphine consumption after mastectomy","volume":"97","author":"Dirks","year":"2002","journal-title":"Anesthesiology"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01263393-201006000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:16:57Z","timestamp":1786040217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01263393-201006000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e328339429a","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}